162 related articles for article (PubMed ID: 12564163)
21. Retinitis pigmentosa. The Friedenwald Lecture.
Berson EL
Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1659-76. PubMed ID: 8473105
[No Abstract] [Full Text] [Related]
22. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse.
Cayouette M; Gravel C
Hum Gene Ther; 1997 Mar; 8(4):423-30. PubMed ID: 9054517
[TBL] [Abstract][Full Text] [Related]
23. Mutation screening of the peropsin gene, a retinal pigment epithelium specific rhodopsin homolog, in patients with retinitis pigmentosa and allied diseases.
Rivolta C; Berson EL; Dryja TP
Mol Vis; 2006 Dec; 12():1511-5. PubMed ID: 17167409
[TBL] [Abstract][Full Text] [Related]
24. [Unexpected findings partly explain the causes of retinitis pigmentosa].
Ehinger B
Lakartidningen; 1990 Apr; 87(17):1458. PubMed ID: 2338852
[No Abstract] [Full Text] [Related]
25. Histologic study of retinitis pigmentosa due to a mutation in the RP13 gene (PRPC8): comparison with rhodopsin Pro23His, Cys110Arg, and Glu181Lys.
To K; Adamian M; Berson EL
Am J Ophthalmol; 2004 May; 137(5):946-8. PubMed ID: 15126168
[TBL] [Abstract][Full Text] [Related]
26. [Retinal pigmentary degeneration--clinical features, diagnostics and possibilities of treatment].
Grześk M; Malukiewicz-Wiśniewska G
Klin Oczna; 2007; 109(4-6):230-4. PubMed ID: 17725295
[TBL] [Abstract][Full Text] [Related]
27. Rod and cone opsin mislocalization in an autopsy eye from a carrier of X-linked retinitis pigmentosa with a Gly436Asp mutation in the RPGR gene.
Adamian M; Pawlyk BS; Hong DH; Berson EL
Am J Ophthalmol; 2006 Sep; 142(3):515-8. PubMed ID: 16935610
[TBL] [Abstract][Full Text] [Related]
28. [Experimental therapeutic modalities for retinitis pigmentosa].
Chowers I; Banin E
Harefuah; 2003 Apr; 142(4):277-80, 317. PubMed ID: 12754878
[TBL] [Abstract][Full Text] [Related]
29. Controlled rod cell ablation in transgenic Xenopus laevis.
Hamm LM; Tam BM; Moritz OL
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):885-92. PubMed ID: 18836175
[TBL] [Abstract][Full Text] [Related]
30. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
Yoshida T; Ozawa Y; Suzuki K; Yuki K; Ohyama M; Akamatsu W; Matsuzaki Y; Shimmura S; Mitani K; Tsubota K; Okano H
Mol Brain; 2014 Jun; 7():45. PubMed ID: 24935155
[TBL] [Abstract][Full Text] [Related]
31. [Progress in treatment of retinitis pigmentosa by neurotrophic factors].
Zhang X; Li GL
Zhonghua Yan Ke Za Zhi; 2009 Sep; 45(9):855-9. PubMed ID: 20137292
[TBL] [Abstract][Full Text] [Related]
32. Residual photosensitivity in mice lacking both rod opsin and cone photoreceptor cyclic nucleotide gated channel 3 alpha subunit.
Barnard AR; Appleford JM; Sekaran S; Chinthapalli K; Jenkins A; Seeliger M; Biel M; Humphries P; Douglas RH; Wenzel A; Foster RG; Hankins MW; Lucas RJ
Vis Neurosci; 2004; 21(5):675-83. PubMed ID: 15683556
[TBL] [Abstract][Full Text] [Related]
33. Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity.
Kanda A; Friedman JS; Nishiguchi KM; Swaroop A
Hum Mutat; 2007 Jun; 28(6):589-98. PubMed ID: 17335001
[TBL] [Abstract][Full Text] [Related]
34. [Research progress of treatment strategies for retinitis pigmentosa].
Qian TW; Xu X
Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):148-153. PubMed ID: 28260368
[TBL] [Abstract][Full Text] [Related]
35. Rod-cone interdependence: implications for therapy of photoreceptor cell diseases.
Sahel JA; Mohand-Said S; Léveillard T; Hicks D; Picaud S; Dreyfus H
Prog Brain Res; 2001; 131():649-61. PubMed ID: 11420978
[No Abstract] [Full Text] [Related]
36. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
[TBL] [Abstract][Full Text] [Related]
37. [Experimental therapeutic modalities for retinitis pigmentosa].
Banin E; Chowers I
Harefuah; 2004 May; 143(5):368-71, 389. PubMed ID: 15190851
[TBL] [Abstract][Full Text] [Related]
38. [Neuroprotective gene therapy to treat patients with retinitis pigmentosa].
Ikeda Y; Ishibashi T
Fukuoka Igaku Zasshi; 2010 Sep; 101(9):183-9. PubMed ID: 21226311
[No Abstract] [Full Text] [Related]
39. [Early therapeutic trials for retinitis pigmentosa].
Dufier JL
Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
[TBL] [Abstract][Full Text] [Related]
40. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse.
Cayouette M; Behn D; Sendtner M; Lachapelle P; Gravel C
J Neurosci; 1998 Nov; 18(22):9282-93. PubMed ID: 9801367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
